Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03810378 · ClinicalTrials.gov registry record · NA
Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03810378: Completed NA study, sponsored by Stanford University.
NCT03810378 is a NA study that has completed, run by Stanford University. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03810378, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of this study is to compare two metabolically distinct diets, WFKD vs Med-Plus, in order to examine the potential benefits, and unintended consequences, of going beyond a focus on maximally avoiding added sugars and refined grains, to also avoiding legumes, fruits, and whole grains.
Interventions
- BEHAVIORAL Mediterranean Diet (Med-Plus)
- BEHAVIORAL Well-Formulated Ketogenic Diet (WFKD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-06-05 |
| Est. Completion | 2020-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03810378
The ClinicalTrials.gov registry entry for NCT03810378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mediterranean Diet (Med-Plus) is the first listed.
NCT03810378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03810378 about?
NCT03810378 is a clinical study titled "Contrasting Ketogenic and Mediterranean Diets in Individuals With Type 2 Diabetes and Prediabetes: The Keto-Med Trial". The objective of this study is to compare two metabolically distinct diets, WFKD vs Med-Plus, in order to examine the potential benefits, and unintended consequences, of going beyond a focus on maximally avoiding added sugars and refined grains, to also avoiding legumes, fruits, and whole grains.
What is the current status of trial NCT03810378?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2019-06-05. Estimated completion is 2020-12-06.
What interventions are being tested in trial NCT03810378?
The interventions under investigation include: Mediterranean Diet (Med-Plus) (BEHAVIORAL), Well-Formulated Ketogenic Diet (WFKD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03810378?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.